Harnessing the Potential of Biosimilars in Retinal Disease Management

home / case-based-roundtable-series / harnessing-the-potential-of-biosimilars-in-retinal-disease-management

Dr Dilsher Dhoot shares his experience of using anti-VEGF biosimilars for managing retinal diseases and presents two patient cases where he achieved significant anatomic improvement by using a ranibizumab biosimilar.

Biosimilars in Retinal Diseases

EP. 1: Biosimilars in Retinal Diseases

Dilsher S. Dhoot, MD
December 8th 2023

Dilsher Dhoot, MD, provides an overview of biosimilars in retinal diseases and discusses how he identifies patients suitable for biosimilar therapy.

Patient Cases Treated with a Ranibizumab Biosimilar

EP. 2: Patient Cases Treated with a Ranibizumab Biosimilar

Dilsher S. Dhoot, MD
December 8th 2023

Dilsher Dhoot, MD, presents two cases involving DME and CRVO, that show remarkable anatomical improvement with a biosimilar comparable to those achieved with reference biologics.

© 2024 MJH Life Sciences

All rights reserved.